OOIR: Observatory of International Research

Papers

(The H4-Index of Inflammopharmacology is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Selenium and selenoproteins: it’s role in regulation of inflammation	305
The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients	196
COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties	138
Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s disease	94
COVID-19 vaccines and decreased transmission of SARS-CoV-2	91
Role of vitamins and minerals as immunity boosters in COVID-19	84
Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update	62
The anti-inflammatory role of SSRI and SNRI in the treatment of depression: a review of human and rodent research studies	52
Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies	51
High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons	48
COVID-19 and the role of cytokines in this disease	44
Alzheimer’s disease: natural products as inhibitors of neuroinflammation	43
Baicalein exerts neuroprotective effect against ischaemic/reperfusion injury via alteration of NF-kB and LOX and AMPK/Nrf2 pathway	43
Health benefits of cyanidin-3-glucoside as a potent modulator of Nrf2-mediated oxidative stress	41
Brief review of the mRNA vaccines COVID-19	40
Empagliflozin suppresses inflammation and protects against acute septic renal injury	38
Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2	38
Polystichum braunii extracts inhibit Complete Freund’s adjuvant-induced arthritis via upregulation of I-κB, IL-4, and IL-10, downregulation of COX-2, PGE2, IL-1β, IL-6, NF-κB, and TNF-α, and subsiding	37
Pathogenesis and management of traumatic brain injury (TBI): role of neuroinflammation and anti-inflammatory drugs	36
Cellular mechanisms and molecular signaling pathways in stress-induced anxiety, depression, and blood–brain barrier inflammation and leakage	35
COVID-19 and corticosteroids: a narrative review	33
Exosome engineering in cell therapy and drug delivery	33
A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality	32
TissueGene-C promotes an anti-inflammatory micro-environment in a rat monoiodoacetate model of osteoarthritis via polarization of M2 macrophages leading to pain relief and structural improvement	32
Novel complementary coloprotective effects of metformin and MCC950 by modulating HSP90/NLRP3 interaction and inducing autophagy in rats	31

Dapagliflozin, an SGLT2 inhibitor, ameliorates acetic acid-induced colitis in rats by targeting NFκB/AMPK/NLRP3 axis	31
Paeoniflorin attenuates chronic constriction injury-induced neuropathic pain by suppressing spinal NLRP3 inflammasome activation	30
Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals	29
A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19	29